Volex plc (LON:VLX – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 663 and last traded at GBX 652, with a volume of 541902 shares changing hands. The stock had previously closed at GBX 651.
Analysts Set New Price Targets
A number of research analysts have issued reports on VLX shares. Jefferies Financial Group reissued a “buy” rating and set a GBX 540 target price on shares of Volex in a research note on Wednesday, April 22nd. Canaccord Genuity Group upped their price target on shares of Volex from GBX 445 to GBX 500 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of GBX 472.50.
View Our Latest Analysis on VLX
Volex Price Performance
Insider Activity
In other news, insider Nathaniel Rothschild purchased 5,000 shares of the business’s stock in a transaction dated Thursday, March 19th. The shares were acquired at an average price of GBX 430 per share, for a total transaction of £21,500. 35.06% of the stock is owned by corporate insiders.
Volex Company Profile
Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 27 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations.
Recommended Stories
- Five stocks we like better than Volex
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Receive News & Ratings for Volex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Volex and related companies with MarketBeat.com's FREE daily email newsletter.
